A multicenter prospective study of next-generation sequencing-based newborn screening for monogenic genetic diseases in China.

We demonstrated that NBGS is an effective strategy to identify neonates affected with treatable diseases as a supplement to current NBS methods. Our data also showed that the prevalence of diseases has significant regional characteristics, which provides a theoretical basis for screening diseases in different regions.